Home > Insider Trading > Filing (0001104659-19-008172)

Filing Details

Accession Number:: 0001104659-19-008172
Form Type:: 5
Zero Holdings:: No
Publication Time:: 2019-02-14 06:09:54
Reporting Period:: 2018-12-31

Accepted Time:: 2019-02-14 06:09:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1496268	Reva Medical Inc.	RVA:AX	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	330810505

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1539490	Ltd Management Capital Senrigan	Po Box 309, Ugland House George Town E9 00000	No	No	Yes	No
1539491	Ltd Group Capital Senrigan	1504 15Th Floor Wheelock House 20 Pedder Street, Central Hong Kong K3 00000	No	No	Yes	No
1627385	Nicholas Taylor	11Th Fl,Lht Tower,31 Queens Road Central Central K3 1	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	Acquisiton	2018-06-29	220,000	$0.00	12,453,969	No	4	P	Indirect	See footnotes
Common Stock, Par Value $0.0001 Per Share	Acquisiton	2018-06-29	17,600	$0.00	12,453,969	No	4	P	Indirect	See footnotes
Common Stock, Par Value $0.0001 Per Share	Acquisiton	2018-06-29	22,400	$0.00	12,453,969	No	4	P	Indirect	See footnotes
Common Stock, Par Value $0.0001 Per Share	Disposition	2018-07-16	134,489	$0.00	12,453,969	No	4	S	Indirect	See footnotes
Common Stock, Par Value $0.0001 Per Share	Disposition	2018-07-20	125,511	$0.00	12,453,969	No	4	S	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnotes
No	4	P	Indirect	See footnotes
No	4	P	Indirect	See footnotes
No	4	S	Indirect	See footnotes
No	4	S	Indirect	See footnotes

Footnotes

Senrigan Capital Management Limited, a Cayman Islands limited company ("SCM") with a business address of PO Box 309,Ugland House, Grand Cayman, KY-1104, is filing this Form 5 jointly with Senrigan Capital Group Limited, a Hong Kong limited company ("SCG"), and Nick Taylor, a citizen of the United Kingdom each of whom has a business address of 11th Floor, LHT Tower, 31 Queens Road Central, Hong Kong and may be deemed to have a pecuniary interest in securities reported by it on this Form 5 ("the Subject Securities"). Collectively, these are the "Reporting Persons."
SCM advises the accounts of the Senrigan Master Fund Limited, a Cayman Islands limited company, Senrigan US Feeder Fund Limited, a Cayman Islands limited company, and Senrigan Fund Limited, a Cayman Islands limited company (together with Senrigan Master Fund Limited and Senrigan US Feeder Fund Limited, the "Senrigan Funds").
SCM, as the investment manager to the Senrigan Funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) of the Securities Exchange Act of 1934. Pursuant to an investment advisory agreement between SCM and SCG, SCG may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Nick Taylor's position as majority owner of SCM, Nick Taylor may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a).
Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.
On June 29, 2018, the Reporting Persons purchased on the open market 2,600,000 CHESS Depository Instruments ("CDI") in Australia, of which US Common Sock underlies at a 1:10 ratio. These purchases were made to facilitate invidual purchases, including the following: Stephen N. Osterle, Brandi Roberts, Robert Bernard Stockman, Raymond C. Larkin Jr., Regina Groves, Richard M Kimes, and Robert Bain Thomas ("Company Insiders"), not to be held for the account of the Reporting Persons. Please see the relevant Form 4 filings made by the Company Insiders for June 29, 2018. These facilitating transactions were completed on 16 July 2018 and 20 July 2018 respectively, leaving the Reporting Persons flat, with no additional common stock acquired.
Consideration was paid jointly by the Reporting Persons for the 2,600,000 CDI for a total compensation of USD $ 399,054. The total consideration paid to the Reporting Persons on 16 July was USD $204,544. The total consideration paid to the Reporting Persons on 20 July was USD $ 192,548. This led to a net loss of USD $1,962 with regard to the facilitation transaction made on behalf of the Company Insiders.